Free Newsletter
New FDA takes a 'moderate' approach
Worried that the Obama administration would usher in a no-tolerance policy toward drug side effects? Well, you can rest easy now. An analysis of Obama's FDA shows that the number of new "black box" warnings dropped by almost half in 2009--to 31 from 56 in 2008.
The new FDA did step up its use of "early communications" to reach the public more quickly and effectively. And it went after more companies producing fake or dangerous products.
The overall picture? A "moderate" approach to regulation--which should relieve some industry anxiety--and new "confidence and certainty" at the agency, the Associated Press reports. "The rank-and-file staffers are now able to move with confidence that the agency has their back," one analyst tells the AP.
- get the AP news
Related Articles:
Changes for a faster, more aggressive FDA
Ex-FDA chief tapped to critique agency
Hamburg 'honeymoon' could aid FDA reform
Can a tough, persuasive Hamburg overhaul FDA?
Shift in enforcement halves FDA warnings
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession






SHARE
WITH: